These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
628 related articles for article (PubMed ID: 27147746)
21. Chloroquine inhibits lytic replication of Kaposi's sarcoma-associated herpesvirus by disrupting mTOR and p38-MAPK activation. Yang M; Huang L; Li X; Kuang E Antiviral Res; 2016 Sep; 133():223-33. PubMed ID: 27521848 [TBL] [Abstract][Full Text] [Related]
22. HIV-1 Vpr Inhibits Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication by Inducing MicroRNA miR-942-5p and Activating NF-κB Signaling. Yan Q; Shen C; Qin J; Li W; Hu M; Lu H; Qin D; Zhu J; Gao SJ; Lu C J Virol; 2016 Oct; 90(19):8739-53. PubMed ID: 27440900 [TBL] [Abstract][Full Text] [Related]
23. Discovery of a Coregulatory Interaction between Kaposi's Sarcoma-Associated Herpesvirus ORF45 and the Viral Protein Kinase ORF36. Avey D; Tepper S; Pifer B; Bahga A; Williams H; Gillen J; Li W; Ogden S; Zhu F J Virol; 2016 Jul; 90(13):5953-5964. PubMed ID: 27099309 [TBL] [Abstract][Full Text] [Related]
24. Reactivation of Kaposi's sarcoma-associated herpesvirus from latency requires MEK/ERK, JNK and p38 multiple mitogen-activated protein kinase pathways. Xie J; Ajibade AO; Ye F; Kuhne K; Gao SJ Virology; 2008 Feb; 371(1):139-54. PubMed ID: 17964626 [TBL] [Abstract][Full Text] [Related]
25. The Kaposi's sarcoma-associated herpesvirus (KSHV) non-structural membrane protein K15 is required for viral lytic replication and may represent a therapeutic target. Abere B; Mamo TM; Hartmann S; Samarina N; Hage E; Rückert J; Hotop SK; Büsche G; Schulz TF PLoS Pathog; 2017 Sep; 13(9):e1006639. PubMed ID: 28938025 [TBL] [Abstract][Full Text] [Related]
26. Transcriptome analysis of Kaposi's sarcoma-associated herpesvirus during de novo primary infection of human B and endothelial cells. Purushothaman P; Thakker S; Verma SC J Virol; 2015 Mar; 89(6):3093-111. PubMed ID: 25552714 [TBL] [Abstract][Full Text] [Related]
27. Cyclooxygenase 2 induced by Kaposi's sarcoma-associated herpesvirus early during in vitro infection of target cells plays a role in the maintenance of latent viral gene expression. Sharma-Walia N; Raghu H; Sadagopan S; Sivakumar R; Veettil MV; Naranatt PP; Smith MM; Chandran B J Virol; 2006 Jul; 80(13):6534-52. PubMed ID: 16775340 [TBL] [Abstract][Full Text] [Related]
28. Genipin Enhances Kaposi's Sarcoma-Associated Herpesvirus Genome Maintenance. Cho M; Jung SW; Lee S; Son K; Park GH; Jung JW; Shin YS; Seo T; Hyosun Cho ; Kang H PLoS One; 2016; 11(10):e0163693. PubMed ID: 27736870 [TBL] [Abstract][Full Text] [Related]
29. Modulation of Kaposi's sarcoma-associated herpesvirus infection and replication by MEK/ERK, JNK, and p38 multiple mitogen-activated protein kinase pathways during primary infection. Pan H; Xie J; Ye F; Gao SJ J Virol; 2006 Jun; 80(11):5371-82. PubMed ID: 16699017 [TBL] [Abstract][Full Text] [Related]
30. The DNase Activity of Kaposi's Sarcoma-Associated Herpesvirus SOX Protein Serves an Important Role in Viral Genome Processing during Lytic Replication. Uppal T; Meyer D; Agarwal A; Verma SC J Virol; 2019 Apr; 93(8):. PubMed ID: 30728255 [TBL] [Abstract][Full Text] [Related]
32. Concurrent Control of the Kaposi's Sarcoma-Associated Herpesvirus Life Cycle through Chromatin Modulation and Host Hedgehog Signaling: a New Prospect for the Therapeutic Potential of Lipoxin A4. Asha K; Balfe N; Sharma-Walia N J Virol; 2020 Apr; 94(9):. PubMed ID: 32102879 [TBL] [Abstract][Full Text] [Related]
33. KSHV activates unfolded protein response sensors but suppresses downstream transcriptional responses to support lytic replication. Johnston BP; Pringle ES; McCormick C PLoS Pathog; 2019 Dec; 15(12):e1008185. PubMed ID: 31790507 [TBL] [Abstract][Full Text] [Related]
34. Localization of Double-Strand Break Repair Proteins to Viral Replication Compartments following Lytic Reactivation of Kaposi's Sarcoma-Associated Herpesvirus. Hollingworth R; Horniblow RD; Forrest C; Stewart GS; Grand RJ J Virol; 2017 Nov; 91(22):. PubMed ID: 28855246 [TBL] [Abstract][Full Text] [Related]
35. [Replication Machinery of Kaposi's Sarcoma-associated Herpesvirus and Drug Discovery Research]. Watanabe T; Fujimuro M Yakugaku Zasshi; 2019; 139(1):69-73. PubMed ID: 30606932 [TBL] [Abstract][Full Text] [Related]
36. ERK1/2 and MEK1/2 induced by Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) early during infection of target cells are essential for expression of viral genes and for establishment of infection. Sharma-Walia N; Krishnan HH; Naranatt PP; Zeng L; Smith MS; Chandran B J Virol; 2005 Aug; 79(16):10308-29. PubMed ID: 16051824 [TBL] [Abstract][Full Text] [Related]
37. Development of an ORF45-Derived Peptide To Inhibit the Sustained RSK Activation and Lytic Replication of Kaposi's Sarcoma-Associated Herpesvirus. Li X; Huang L; Xiao Y; Yao X; Long X; Zhu F; Kuang E J Virol; 2019 May; 93(10):. PubMed ID: 30842327 [TBL] [Abstract][Full Text] [Related]
38. Kang SK; Kang YH; Yoo SM; Park C; Kim HS; Lee MS J Virol; 2021 Jul; 95(16):e0079921. PubMed ID: 34105998 [TBL] [Abstract][Full Text] [Related]
39. Upregulation of MicroRNA 711 Mediates HIV-1 Vpr Promotion of Kaposi's Sarcoma-Associated Herpesvirus Latency and Induction of Pro-proliferation and Pro-survival Cytokines by Targeting the Notch/NF-κB-Signaling Axis. Yan Q; Zhao R; Shen C; Wang F; Li W; Gao SJ; Lu C J Virol; 2018 Sep; 92(18):. PubMed ID: 29976660 [TBL] [Abstract][Full Text] [Related]
40. Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen inhibits lytic replication by targeting Rta: a potential mechanism for virus-mediated control of latency. Lan K; Kuppers DA; Verma SC; Robertson ES J Virol; 2004 Jun; 78(12):6585-94. PubMed ID: 15163750 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]